Rheumatologist
About the job
- A Medical Degree (MD or DO) from an accredited institution is required.
- Completion of an ACGME-accredited residency in Internal Medicine is required.
- Completion of a Rheumatology fellowship program is required.
- An unrestricted Pennsylvania medical license, or the ability to obtain one, is required.
- Board certification or board eligibility in Rheumatology is required.
- BLS/ACLS certification is required as applicable.
- The role requires a commitment to patient-centered care and teamwork.
- Strong clinical and communication skills are required.
- Provide outpatient evaluation, diagnosis, and management of rheumatologic conditions.
- Develop comprehensive, individualized treatment plans for patients with autoimmune and inflammatory diseases.
- Manage chronic conditions such as rheumatoid arthritis, lupus, vasculitis, and other connective tissue disorders.
- Collaborate with primary care and specialty providers to ensure coordinated care.
- Use evidence-based practices and clinical guidelines.
- Document patient encounters in accordance with regulatory and organizational standards.
- Participate in quality improvement initiatives and team-based care models.
- Maintain timely communication with patients, families, and referring providers.
- Attend required meetings and maintain all necessary certifications.
- Perform other duties as assigned.
- Build and shape an outpatient practice within the Main Line Health network.
- Two or more years of outpatient Rheumatology experience is preferred. New graduates are welcome.
About the company
Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Lancaster, Pennsylvania
Founded
1927
Get referred to Main Line Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Fitch kept Main Line Health at AA with a stable outlook on October 28, 2025.
- June 2026 revenue reached $2.1 billion, aided by Crozer closures shifting regional demand.
- Paoli’s June 16, 2026 expansion adds 108 beds and supports higher-acuity volume growth.
What critics are saying
- The January 2025 200-person layoff exposed reimbursement pressure and overhead dependence.
- The October 2025 NLRB case with Local 835 signals ongoing labor friction at Lankenau.
- The August 2026 whistleblower lawsuit over cardiac complications threatens trust, referrals, and surgeon recruitment.
What makes Main Line Health unique
- LIMR gives Main Line Health a rare translational research engine inside a hospital system.
- Paoli, Lankenau, Bryn Mawr, and Riddle create a tightly integrated Philadelphia suburban network.
- The 2026 Saint Joseph’s exclusive-provider deal expands brand visibility beyond traditional hospital care.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Pension
- 403(b) Retirement Plan
- Unlimited Paid Time Off
- Tuition Reimbursement
- Wellness Program
- Family Planning Benefits